Moreover, most published works
conclude about the use of a specific pre-treatment on the basis
of minimum values obtained for the standard errors of cross
validation (SECV) or standard errors of prediction (SEP). This
is risky, because any improvement is confounded by other
factors, for example outlier rejection.